Analyst Price Targets — IRIX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 27, 2026 12:53 pm | — | Industrial Alliance Securities | $2.75 | $0.99 | TheFly | Iridex price target lowered to $2.75 from $3 at Alliance Global |
| February 5, 2026 3:52 pm | — | Industrial Alliance Securities | $3.00 | $1.47 | TheFly | Iridex initiated with a Buy at Alliance Global |
Latest News for IRIX
MOUNTAIN VIEW, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a new partnership with EyeProGPO, an ophthalmology-focused group purchasing organization serving ophthalmology practices, ambulatory surgery…
IRIX incurs narrower year-over-year loss per share in Q4 as growth in retina systems and glaucoma probes boosts revenues, though margins remain pressured by higher costs.
IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript
Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies Strong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies
IRIDEX (NASDAQ: IRIX - Get Free Report) is expected to issue its Q4 2025 results before the market opens on Thursday, March 26th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $14.74 million for the quarter. Individuals are encouraged to explore the company's upcoming Q4 2025 earning overview page for
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for IRIX.
U.S. House Trading
No House trades found for IRIX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.